Author Archives: Clark Herman

The Sunshine Act Makes for Gloomy Sales Reps

On Café Pharma message boards, the drug industry’s online water cooler, anonymous sales reps are sounding off on the Physician Payment Sunshine Act and its implications for their battered profession. Here’s a selection from a thread that PharmExec came across, edited for spelling, punctuation, and coherence:
Posted in Advertising, compliance, Marketing, Medical Education, Regulatory, Sales, social media | Tagged , , , | 2 Comments

Omnicom and Publicis: Musings on the Merger

With the pharma industry spending over $31 billion a year on product promotion, the melding of ad giants Omnicom and Publicis beckons a closer look. The two holding companies lent ink to their union in Paris at the end of last month. Since then, a number of perspectives on the deal have surfaced, many of […]
Posted in Advertising, Agency Insight, Deals, E-Media, Global, Marketing, Strategy | Tagged , , , , , , , , , | Leave a comment

Roche Jumps into Medicines Patent Pool with Pricing and Licensing Deal

Roche this week has announced a partnership with the UN-backed Medicines Patent Pool (MPP) to provide its drug valganciclovir, better known in the developed world as Valcyte, in 138 countries for a reduced price. In addition to making the drug available in these markets for up to 90% cheaper than current price, Roche has decided […]
Posted in Corporate Responsibility, Deals, Emerging Markets, Global, IP, Market Access, pricing | Tagged , , , , , , , , , , , , , , , , , , , , | Leave a comment

The List So Far: FDA Breakthrough Designations

With announcements pouring in since the beginning of this year, FDA’s fourth and newest expedited approval pathway for medicines has begun to bear fruit. Established in 2012 within the FDA Safety and Innovation Act (FDASIA), Breakthrough Therapy designations have so far totaled 25 as of the end of July. With a separate senior management team […]
Posted in Biotech, FDA, Orphan Drugs, Regulatory | Tagged , , , , , , , , , , , , | Leave a comment

Six Steps to Better Medicines Adherence

On Friday, the New England Health Institute (NEHI), outlined six “Priorities for Action” to help steer the solution to better medication adherence in the US. These priorities signal public and private policymakers alike to improve the way patients take their medication.
Posted in healthcare, Medical Education, Patient Communication, patient compliance, R&D, Strategy | Tagged , , , | Leave a comment
  • Categories

  • Meta